Loxo Oncology Inc (LOXO)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 125.00 / 234.93
Exchange NASDAQ
Div & Yield N.A. (N.A)
Loxo Oncology Announces First Patient Enrolled In LOXO-101 Phase 2 Basket Trial In Patients With Solid Tumors Harboring TRK Fusions

Loxo Oncology Announces First Patient Enrolled In LOXO-101 Phase 2 Basket Trial In Patients With Solid Tumors Harboring TRK Fusions

New Phase 1 Data Has Been Accepted for an Oral, Late-Breaking Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Market News: Loxo Oncology, Masco Corp, Twitter Inc

Market News: Loxo Oncology, Masco Corp, Twitter Inc

The stock markets in the United States rebounded and halted its longest losing streak amid better-than-expected corporate earnings today. The Dow Jones gained 1.09% and the S&P 500 climbed 1.24%. ...

Loxo Oncology is Now Oversold (LOXO)

Loxo Oncology is Now Oversold (LOXO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.